[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1129191T3 - Fremgangsmåder til diagnosticering eller behandling af neurologiske sygdomme - Google Patents

Fremgangsmåder til diagnosticering eller behandling af neurologiske sygdomme

Info

Publication number
DK1129191T3
DK1129191T3 DK99960975T DK99960975T DK1129191T3 DK 1129191 T3 DK1129191 T3 DK 1129191T3 DK 99960975 T DK99960975 T DK 99960975T DK 99960975 T DK99960975 T DK 99960975T DK 1129191 T3 DK1129191 T3 DK 1129191T3
Authority
DK
Denmark
Prior art keywords
diagnosing
methods
neurological diseases
treating neurological
treating
Prior art date
Application number
DK99960975T
Other languages
English (en)
Inventor
Roger Nitsch
Isabell Greeve
Original Assignee
Evotec Neurosciences Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evotec Neurosciences Gmbh filed Critical Evotec Neurosciences Gmbh
Application granted granted Critical
Publication of DK1129191T3 publication Critical patent/DK1129191T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711Alzheimer's disease; Amyloid plaque core protein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Psychology (AREA)
  • General Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
DK99960975T 1998-11-12 1999-11-12 Fremgangsmåder til diagnosticering eller behandling af neurologiske sygdomme DK1129191T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98121478A EP1002862A1 (en) 1998-11-12 1998-11-12 Methods of diagnosing or treating neurological diseases

Publications (1)

Publication Number Publication Date
DK1129191T3 true DK1129191T3 (da) 2006-07-17

Family

ID=8232965

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99960975T DK1129191T3 (da) 1998-11-12 1999-11-12 Fremgangsmåder til diagnosticering eller behandling af neurologiske sygdomme

Country Status (8)

Country Link
US (2) US20050239169A1 (da)
EP (2) EP1002862A1 (da)
JP (1) JP4663121B2 (da)
AT (1) ATE321135T1 (da)
DE (1) DE69930545T2 (da)
DK (1) DK1129191T3 (da)
ES (1) ES2262352T3 (da)
WO (1) WO2000029569A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012525A1 (en) * 1998-08-27 2000-03-09 Quark Biotech, Inc. Sequences characteristic of hypoxia-regulated gene transcription
AU2002236503C1 (en) * 2000-11-28 2008-11-13 Wyeth Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
US20050059001A1 (en) * 2001-05-31 2005-03-17 Akira Nakagawara Nucleic acids isolated in neuroblastoma
US20030068636A1 (en) 2001-06-21 2003-04-10 Millennium Pharmaceuticals, Inc. Compositions, kits and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
US20060099585A1 (en) * 2002-05-28 2006-05-11 Evoctec Neurosciences Gmbh Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases
EP2298807A3 (en) 2004-07-30 2011-05-18 Rinat Neuroscience Corp. Antibodies directed against amyloid-beta peptide and methods using same
UY29504A1 (es) 2005-04-29 2006-10-31 Rinat Neuroscience Corp Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
CN111788126B (zh) * 2018-04-13 2022-03-04 株式会社胜一 可解除过压的喷射容器及其阀门组件

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0814157A3 (en) * 1996-06-18 1998-01-07 Smithkline Beecham Corporation Diagnostic marker for variants of presenilin genes associated with Alzheimers Disease and Familial Adult Onset Alzheimers Disease
WO2000012525A1 (en) * 1998-08-27 2000-03-09 Quark Biotech, Inc. Sequences characteristic of hypoxia-regulated gene transcription

Also Published As

Publication number Publication date
WO2000029569A1 (en) 2000-05-25
EP1129191A1 (en) 2001-09-05
JP2002530076A (ja) 2002-09-17
ATE321135T1 (de) 2006-04-15
US20080261302A1 (en) 2008-10-23
US20050239169A1 (en) 2005-10-27
DE69930545T2 (de) 2007-03-08
DE69930545D1 (de) 2006-05-11
EP1002862A1 (en) 2000-05-24
ES2262352T3 (es) 2006-11-16
JP4663121B2 (ja) 2011-03-30
EP1129191B1 (en) 2006-03-22

Similar Documents

Publication Publication Date Title
DE69636495D1 (de) Multi-tumor abweichende wachstumsgene
CY1106978T1 (el) Ενζυμα φωσφοδιεστερασης
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
ES545725A0 (es) Procedimiento para preparar peptidos de interferon
DK2256205T3 (da) Porphorymonas gingivalis-polypeptider og -polynukleotider
DK0920501T3 (da) Neuritin, et neurogen
DK1129191T3 (da) Fremgangsmåder til diagnosticering eller behandling af neurologiske sygdomme
ATE223491T1 (de) Verfahren zur reinigung von biomolekül- oder proteinkomplexen
DK1108786T3 (da) Hidtil ukendt kollektin
DE69739071D1 (de) Menschliche tak1 und für diese kodierende dna
DK0923644T3 (da) G-koblet receptor, der udviser selektiv selektivitet for ATP
NO942443L (no) Gen kodende for kationisk aminosyre transporter protein
EP0816498A3 (en) Excitatory amino acid receptor protein and related nucleic acid compounds
EP0911408A3 (en) DNA coding for serine/threonine kinase
DE69731682D1 (de) TAB1 Protein und dafür kodierende DNA
EE200100234A (et) PRV-1-geen ja selle kasutamine
ATE304553T1 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
FR2757524B1 (fr) Polypeptides de la famille bhlh, sequences d'acides nucleiques correspondantes
DE69943149D1 (en) Serinprotease bssp2
WO2003060074A3 (en) Novel metastasis suppressor gene on human chromosome 8
BR0107799A (pt) Proteìna de interação de wt1 wtip